The impact of ticagrelor therapy on CABG-related bleeding in patients with STEMI managed with pPCI and following on-pump CABG
Durmaz E, Ikitimur B, Arapi B, Tel Ustunisik C, Soysal A, İncesu G, Gulfidan A, Yalman H, Cidem S, Tokdil H, Raimoglu U, Raimoglou D, Akman Z, Atici A, Karadag B. The impact of ticagrelor therapy on CABG-related bleeding in patients with STEMI managed with pPCI and following on-pump CABG. Heart And Vessels 2024, 40: 1-7. PMID: 39030310, DOI: 10.1007/s00380-024-02434-1.Peer-Reviewed Original ResearchConceptsCABG-related bleedingST-segment elevation myocardial infarctionCoronary Artery Bypass GraftingLong-term cardiovascular eventsCABG surgeryRisk of long-term cardiovascular eventsCardiovascular eventsMechanical cardiac support devicesIn-hospital coronary artery bypass graftingOn-pump coronary artery bypass graftingAssociated with long-term cardiovascular eventsOn-pump CABG surgeryDiagnosis of ST-segment elevation myocardial infarctionDay of surgeryShort-term cardiovascular outcomesArtery Bypass GraftingElevation myocardial infarctionCardiac support devicePercutaneous coronary interventionTicagrelor doseTicagrelor therapyNo significant differenceStudy patientsAntiplatelet treatmentRetrospective study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply